Related Experiment Video
Updated: Jul 18, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Diagnostic and therapeutic algorithms in chronic heart failure
1Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden. karl.swedberg@gu.se
Herz
|December 21, 2006
Summary
Chronic heart failure (CHF) management has improved, reducing mortality. Optimal care requires diagnosis, symptom management, and guideline-adherent neurohormonal antagonist therapy for better prognosis.
Area of Science:
- Cardiology
- Clinical Medicine
- Pharmacotherapy
Background:
- Chronic heart failure (CHF) treatment has advanced, significantly reducing mortality and morbidity over the past decade.
- Despite improvements, CHF remains a leading cause of mortality and incurs substantial healthcare costs due to frequent hospitalizations.
Observation:
- Current best practices for CHF management involve accurate diagnosis, risk stratification, and symptomatic treatment of fluid overload.
- Prognosis is improved by combining at least two neurohormonal antagonists, necessitating a structured management approach.
Findings:
- Major European and North American guidelines are harmonized, based on consistent evidence for CHF treatment.
- A recent comparison of four key guideline documents revealed some differences in evidence interpretation.
Implications:
- Harmonized guidelines aim to standardize and promote optimal CHF treatment implementation.
- Understanding guideline nuances is crucial for refining clinical practice and improving patient outcomes in chronic heart failure care.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...